Torsten Falk

Neurology University of Arizona, Tucson, AZ 
"Torsten Falk"
Mean distance: (not calculated yet)


Sign in to add mentor
Dietmar Richter grad student 1992-1996 University of Hamburg
Juergen Schwarz grad student 1992-1996 University of Hamburg
Andrea J. Yool post-doc 1996-2001 University of Arizona (Cell Biology Tree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ye T, Bartlett MJ, Sherman SJ, et al. (2021) Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine. Experimental Neurology. 113670
Young KF, Gardner R, Sariana V, et al. (2021) Can quantifying morphology and TMEM119 expression distinguish between microglia and infiltrating macrophages after ischemic stroke and reperfusion in male and female mice? Journal of Neuroinflammation. 18: 58
Bartlett MJ, Mabrouk OS, Szabò L, et al. (2020) The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia. International Journal of Molecular Sciences. 22
Bartlett MJ, Flores AJ, Ye T, et al. (2020) Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia. Experimental Neurology. 113413
Crown LM, Bartlett MJ, Wiegand JL, et al. (2020) Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease. Frontiers in Neurology. 11: 324
Bartlett MJ, So LY, Szabò L, et al. (2020) Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model. Bmc Research Notes. 13: 149
Hay M, Polt R, Heien ML, et al. (2019) A Novel Angiotensin-(1-7)-glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation Related Memory Dysfunction. The Journal of Pharmacology and Experimental Therapeutics
Flores AJ, Bartlett MJ, Root BK, et al. (2018) The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia. Neuropharmacology. 141: 260-271
Ye T, Bartlett MJ, Schmit MB, et al. (2018) Ten-Hour Exposure to Low-Dose Ketamine Enhances Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma Oscillations. Frontiers in Neural Circuits. 12: 61
Caballero B, Sherman SJ, Falk T. (2017) Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons. Parkinson's Disease. 2017: 4263795
See more...